The journey to zero deep-vein thrombosis in critically ill patients

Abstract

P of deep‐vein thrombosis (DVT) among critically ill patients has been considered a high priority for patient safety initiatives.[1] Recently, the Saudi Critical Care Trials Group published the results of the Pneumatic Compression for Preventing Venous Thromboembolism (PREVENT) trial in the New England Journal of Medicine.[2] The trial examined whether the addition of pneumatic compression to pharmacological thromboprophylaxis reduced the incidence of DVT in critically ill patients.[2‐4] In this commentary, we review the lessons learned and implications of the PREVENT trial on clinical practice.